SEC Form SC 13G/A filed by MaxCyte Inc. (Amendment)

2/13/23 2:08:01 PM ET

$MXCT

Biotechnology: Commercial Physical & Biological Resarch

Health Care

Get the next $MXCT alert in real time by email

SC 13G/A 1 tm236518d2_sc13ga.htm SC 13G/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

(Rule 13d-102)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED

PURSUANT TO RULE 13d-2

(Amendment No. 1) *

MaxCyte, Inc.

(Name of Issuer)

Common stock, par value $0.01 per share

(Title of Class of Securities)

57777K106
(CUSIP Number)

December 31, 2022

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)

¨ Rule 13d-1(c)

x Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP NO. 57777K106

Page 2 of 14 Pages

1	NAMES OF REPORTING PERSONS Sofinnova Crossover I SLP (“SC”)
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) ¨ (b) x
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION France

NUMBER OF

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

SOLE VOTING POWER

4,610,693 shares, except that Sofinnova Partners SAS, a French corporation (“SP SAS”), the management company of SC, may be deemed to have sole voting power, and Antoine Papiernik (“Papiernik”), Monique Saulnier (“Saulnier”), Cédric Moreau (“Moreau”), Kinam Hong (“Hong”), Thomas Burt (“Burt”), Joseph Anderson (“Anderson”) and Jacques Theurillat (“Theurillat”), the members of the investment committee of SC, may be deemed to have shared power to vote these shares.

SHARED VOTING POWER

See row 5.

SOLE DISPOSITIVE POWER

4,610,693 shares, except that SP SAS, the management company of SC, may be deemed to have sole voting power, and Papiernik, Saulnier, Moreau, Hong, Burt, Anderson and Theurillat, the members of the investment committee of SC, may be deemed to have shared power to vote these shares.

SHARED DISPOSITIVE POWER

See row 7.

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,610,693 shares
10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) ¨
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 4.5%
12	TYPE OF REPORTING PERSON (See Instructions) OO

CUSIP NO. 57777K106

Page 3 of 14 Pages

1	NAMES OF REPORTING PERSONS Sofinnova Partners SAS, a French corporation (“SP SAS”)
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) ¨ (b) x
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION France

NUMBER OF

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

SOLE VOTING POWER

4,610,693 shares; SP SAS, the management company of SC, may be deemed to have sole voting power, and Papiernik, Saulnier, Moreau, Hong, Burt, Anderson and Theurillat, the members of the investment committee of SC, may be deemed to have shared power to vote these shares.

SHARED VOTING POWER

See row 5.

SOLE DISPOSITIVE POWER

4,610,693 shares; SP SAS, the management company of SC, may be deemed to have sole power to dispose of these shares, and Papiernik, Saulnier, Moreau, Hong, Burt, Anderson and Theurillat, the members of the investment committee of SC, may be deemed to have shared power to dispose of these shares.

SHARED DISPOSITIVE POWER

See row 7.

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,610,693 shares
10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) ¨
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 4.5%
12	TYPE OF REPORTING PERSON (See Instructions) OO

CUSIP NO. 57777K106

Page 4 of 14 Pages

1	NAMES OF REPORTING PERSONS Antoine Papiernik (“Papiernik”)
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) ¨ (b) x
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION French Citizen

NUMBER OF

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

SOLE VOTING POWER

4,610,693 shares; SP SAS, the management company of SC, may be deemed to have sole voting power, and Papiernik, a member of the investment committee of SC, may be deemed to have shared power to vote these shares.

SHARED VOTING POWER

See row 5.

SOLE DISPOSITIVE POWER

4,610,693 shares; SP SAS, the management company of SC, may be deemed to have sole power to dispose of these shares, and Papiernik, a member of the investment committee of SC, may be deemed to have shared power to dispose of these shares.

SHARED DISPOSITIVE POWER

See row 7.

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,610,693 shares
10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) ¨
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 4.5%
12	TYPE OF REPORTING PERSON (See Instructions) IN

CUSIP NO. 57777K106

Page 5 of 14 Pages

1	NAMES OF REPORTING PERSONS Monique Saulnier (“Saulnier”)
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) ¨ (b) x
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION French Citizen

NUMBER OF

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

SOLE VOTING POWER

4,610,693 shares; SP SAS, the management company of SC, may be deemed to have sole voting power, and Saulnier, a member of the investment committee of SC, may be deemed to have shared power to vote these shares.

SHARED VOTING POWER

See row 5.

SOLE DISPOSITIVE POWER

4,610,693 shares; SP SAS, the management company of SC, may be deemed to have sole power to dispose of these shares, and Saulnier, a member of the investment committee of SC, may be deemed to have shared power to dispose of these shares.

SHARED DISPOSITIVE POWER

See row 7.

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,610,693 shares
10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) ¨
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 4.5%
12	TYPE OF REPORTING PERSON (See Instructions) IN

CUSIP NO. 57777K106

Page 6 of 14 Pages

1	NAMES OF REPORTING PERSONS Cédric Moreau
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) ¨ (b) x
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION French Citizen

NUMBER OF

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

SOLE VOTING POWER

4,610,693 shares; SP SAS, the management company of SC, may be deemed to have sole voting power, and Moreau, a member of the investment committee of SC, may be deemed to have shared power to vote these shares.

SHARED VOTING POWER

See row 5.

SOLE DISPOSITIVE POWER

4,610,693 shares; SP SAS, the management company of SC, may be deemed to have sole power to dispose of these shares, and Moreau, a member of the investment committee of SC, may be deemed to have shared power to dispose of these shares.

SHARED DISPOSITIVE POWER

See row 7.

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,610,693 shares
10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) ¨
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 4.5%
12	TYPE OF REPORTING PERSON (See Instructions) IN

CUSIP NO. 57777K106

Page 7 of 14 Pages

1	NAMES OF REPORTING PERSONS Kinam Hong (“Hong”)
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) ¨ (b) x
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION U.S.A. Citizen

NUMBER OF

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

SOLE VOTING POWER

4,610,693 shares; SP SAS, the management company of SC, may be deemed to have sole voting power, and Hong, a member of the investment committee of SC, may be deemed to have shared power to vote these shares.

SHARED VOTING POWER

See row 5.

SOLE DISPOSITIVE POWER

4,610,693 shares; SP SAS, the management company of SC, may be deemed to have sole power to dispose of these shares, and Hong, a member of the investment committee of SC, may be deemed to have shared power to dispose of these shares.

SHARED DISPOSITIVE POWER

See row 7.

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,610,693 shares
10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) ¨
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 4.5%
12	TYPE OF REPORTING PERSON (See Instructions) IN

CUSIP NO. 57777K106

Page 8 of 14 Pages

1	NAMES OF REPORTING PERSONS Thomas Burt (“Burt”)
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) ¨ (b) x
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION British Citizen

NUMBER OF

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

SOLE VOTING POWER

4,610,693 shares; SP SAS, the management company of SC, may be deemed to have sole voting power, and Burt, a member of the investment committee of SC, may be deemed to have shared power to vote these shares.

SHARED VOTING POWER

See row 5.

SOLE DISPOSITIVE POWER

4,610,693 shares; SP SAS, the management company of SC, may be deemed to have sole power to dispose of these shares, and Burt, a member of the investment committee of SC, may be deemed to have shared power to dispose of these shares.

SHARED DISPOSITIVE POWER

See row 7.

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,610,693 shares
10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) ¨
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 4.5%
12	TYPE OF REPORTING PERSON (See Instructions) IN

CUSIP NO. 57777K106

Page 9 of 14 Pages

1	NAMES OF REPORTING PERSONS Joseph Anderson (“Anderson”)
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) ¨ (b) x
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION British Citizen

NUMBER OF

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

SOLE VOTING POWER

4,610,693 shares; SP SAS, the management company of SC, may be deemed to have sole voting power, and Anderson, a member of the investment committee of SC, may be deemed to have shared power to vote these shares.

SHARED VOTING POWER

See row 5.

SOLE DISPOSITIVE POWER

4,610,693 shares; SP SAS, the management company of SC, may be deemed to have sole power to dispose of these shares, and Anderson, a member of the investment committee of SC, may be deemed to have shared power to dispose of these shares.

SHARED DISPOSITIVE POWER

See row 7.

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,610,693 shares
10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) ¨
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 4.5%
12	TYPE OF REPORTING PERSON (See Instructions) IN

CUSIP NO. 57777K106

Page 10 of 14 Pages

1	NAMES OF REPORTING PERSONS Jacques Theurillat (“Theurillat”)
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) ¨ (b) x
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION Swiss Citizen

NUMBER OF

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

SOLE VOTING POWER

4,610,693 shares; SP SAS, the management company of SC, may be deemed to have sole voting power, and Theurillat, a member of the investment committee of SC, may be deemed to have shared power to vote these shares.

SHARED VOTING POWER

See row 5.

SOLE DISPOSITIVE POWER

4,610,693 shares; SP SAS, the management company of SC, may be deemed to have sole power to dispose of these shares, and Theurillat, a member of the investment committee of SC, may be deemed to have shared power to dispose of these shares.

SHARED DISPOSITIVE POWER

See row 7.

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,610,693 shares
10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) ¨
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 4.5%
12	TYPE OF REPORTING PERSON (See Instructions) IN

CUSIP NO. 57777K106

Page 11 of 14 Pages

Item 1 (a).

Name of Issuer: MaxCyte, Inc.

Item 1 (b).              Address of Issuer’s Principal Executive Offices: 22 Firstfield Road, Suite 110, Gaithersburg, Maryland 20878

Item 2 (a).              Name of Person Filing: The persons and entities filing this Schedule 13G are Sofinnova Crossover I SLP (“SC”), Sofinnova Partners SAS (“SP SAS”), and Antoine Papiernik (“Papiernik”), Monique Saulnier (“Saulnier”), Cédric Moreau (“Moreau), Kinam Hong (“Hong”) , Thomas Burt (“Burt”), Joseph Anderson (“Anderson”) and Jacques Theurillat (“Theurillat”), the members of the investment committee of SC (together with SC and SP SAS, the “Filing Persons”). SP SAS is the management company of SC.

Item 2 (b).              Address of Principal Business Office or, if none, Residence: The address of the principal place of business for each of the Filing Persons is Sofinnova Partners SAS, 7-11 boulevard Hausmann 75009 Paris, France.

Item 2 (c).              Citizenship: SC is a French Partnership. SP SAS is a French Corporation. Papiernik, Saulnier and Moreau are French citizens. Hong is U.S.A. citizen. Burt and Anderson are British citizens. Theurillat is a Swiss citizen.

Item 2 (d).

Title of Class of Securities: Common stock, par value $0.01 per share

Item 2 (e).

CUSIP Number: 57777K106

Item 3.

If this Statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

(a)	¨	Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o);

(b)	¨	Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c);

(c)	¨	Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c);

(d)	¨	Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);

(e)	¨	An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);

(f)	¨	An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);

(g)	¨	A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);

(h)	¨	A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i)	¨	A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j)	¨	A non-U.S. institution, in accordance with §240.13d-1(b)(1)(ii)(J);

(k)	¨	Group, in accordance with §240.13d-1(b)(1)(ii)(K).

If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution.

Not applicable.

CUSIP NO. 57777K106

Page 12 of 14 Pages

Item 4.

Ownership

(a)

Amount beneficially owned: See Row 9 of the cover page for each of the Filing Persons. Each Filing Person disclaims beneficial ownership with respect to these shares except to the extent of such Filing Person’s pecuniary interest therein.

	(b)	Percent of class: See Row 10 of the cover page for each of the Filing Persons.

	(c)	Number of shares as to which such person has:

(i)

Sole power to vote or to direct the vote: See Row 5 of the cover page for each of the Filing Persons.

(ii)

Shared power to vote or to direct the vote. See Row 6 of the cover page for each of the Filing Persons.

(iii)

Sole power to dispose or to direct the disposition of: See Row 7 of the cover page for each of the Filing Persons.

(iv)

Shared power to dispose or to direct the disposition of: See Row 8 of the cover page for each of the Filing Persons.

Item 5.

Ownership of Five Percent or Less of a Class

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following x.

Item 6.

Ownership of More than Five Percent on Behalf of Another Person

Not applicable.

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person

Not applicable.

Item 8.

Identification and Classification of Members of the Group

Not applicable.

Item 9.

Notice of Dissolution of Group

Not applicable.

Item 10.

Certifications.

Not Applicable.

CUSIP NO. 57777K106

Page 13 of 14 Pages

SIGNATURE

After reasonable inquiry and to the best of the undersigneds' knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

Dated: February 10, 2023

SOFINNOVA CROSSOVER I SLP		SOFINNOVA PARTNERS SAS
By: Sofinnova Partners SAS

		By:	/s/ Monique Saulnier
By:	/s/ Monique Saulnier	Name:	Monique Saulnier
Name:	Monique Saulnier	Title:	Managing Partner
Title:	Managing Partner

By:	/s/ Antoine Papiernik	By:	/s/ Monique Saulnier
Name:	Antoine Papiernik	Name:	Monique Saulnier

By:	/s/ Cédric Moreau	By:	/s/ Kinam Hong
Name:	Cédric Moreau	Name:	Kinam Hong

By:	/s/ Thomas Burt	By:	/s/ Joseph Anderson
Name:	Thomas Burt	Name:	Joseph Anderson

By:	/s/ Jacques Theurillat
Name:	Jacques Theurillat

CUSIP NO. 57777K106

Page 14 of 14 Pages

EXHIBITS

Exhibit No.		Description

99.1		Joint Filing Agreement, dated as of February 10, 2022, by and among Sofinnova Crossover I SLP, Sofinnova Partners SAS, Antoine Papiernik, Monique Saulnier, Cédric Moreau, Kinam Hong, Thomas Burt, Joseph Anderson and Jacques Theurillat (incorporated by reference to Exhibit 99.1 to the Schedule 13G filed by Sofinnova Crossover I SLP on February 11, 2022).

Get the next $MXCT alert in real time by email

Date	Price Target	Rating	Analyst
11/29/2023	$7.00	Buy	Craig Hallum
10/15/2021		Outperform	Cowen
8/24/2021	$36.00	Outperform	Wedbush
8/24/2021		Outperform	William Blair
8/24/2021	$19.00	Overweight	Stephens
8/24/2021		Outperform	Cowen & Co.
8/24/2021	$18.00	Buy	Stifel
8/24/2021	$22.00	Buy	BTIG

SEC Form SC 13G/A filed by MaxCyte Inc. (Amendment)

Chat with this insight

Recent Analyst Ratings for
$MXCT

$MXCT
Financials

Live finance-specific insights

MaxCyte Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Guidance

MaxCyte to Report First Quarter 2025 Financial Results on May 7, 2025

MaxCyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Guidance

$MXCT
Large Ownership Changes

This live feed shows all institutional transactions in real time.

Amendment: SEC Form SC 13G/A filed by MaxCyte Inc.

Amendment: SEC Form SC 13G/A filed by MaxCyte Inc.

SEC Form SC 13G filed by MaxCyte Inc.

$MXCT
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Chief Commercial Officer Soleymannezhad Ali sold $3,850 worth of shares (1,211 units at $3.18), decreasing direct ownership by 2% to 59,439 units (SEC Form 4)

GENERAL COUNSEL Sandoval David I. sold $1,122 worth of shares (353 units at $3.18), decreasing direct ownership by 0.55% to 64,219 units (SEC Form 4)

CHIEF FINANCIAL OFFICER Swirsky Douglas J sold $22,061 worth of shares (6,939 units at $3.18), decreasing direct ownership by 6% to 111,811 units (SEC Form 4)

$MXCT
SEC Filings

SEC Form 10-Q filed by MaxCyte Inc.

MaxCyte Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

SEC Form DEF 14A filed by MaxCyte Inc.

$MXCT
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Craig Hallum initiated coverage on MaxCyte with a new price target

Cowen resumed coverage on MaxCyte

Wedbush initiated coverage on MaxCyte with a new price target

$MXCT
Leadership Updates

Live Leadership Updates

MaxCyte Announces Streamlined Operations and Raises 2024 Revenue Guidance

MaxCyte Appoints Cynthia Collins to its Board of Directors

MaxCyte Appoints Ali Soleymannezhad as Chief Commercial Officer

$MXCT
Press Releases

Fastest customizable press release news feed in the world

MaxCyte Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Guidance

MaxCyte to Report First Quarter 2025 Financial Results on May 7, 2025

MaxCyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Guidance

$MXCT
Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

President and CEO Masoud Maher bought $489,066 worth of shares (100,000 units at $4.89) (SEC Form 4)

SEC Form SC 13G/A filed by MaxCyte Inc. (Amendment)

Chat with this insight

Recent Analyst Ratings for $MXCT

$MXCT Financials

Live finance-specific insights

MaxCyte Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Guidance

MaxCyte to Report First Quarter 2025 Financial Results on May 7, 2025

MaxCyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Guidance

$MXCT Large Ownership Changes

This live feed shows all institutional transactions in real time.

Amendment: SEC Form SC 13G/A filed by MaxCyte Inc.

Amendment: SEC Form SC 13G/A filed by MaxCyte Inc.

SEC Form SC 13G filed by MaxCyte Inc.

$MXCT Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Chief Commercial Officer Soleymannezhad Ali sold $3,850 worth of shares (1,211 units at $3.18), decreasing direct ownership by 2% to 59,439 units (SEC Form 4)

GENERAL COUNSEL Sandoval David I. sold $1,122 worth of shares (353 units at $3.18), decreasing direct ownership by 0.55% to 64,219 units (SEC Form 4)

CHIEF FINANCIAL OFFICER Swirsky Douglas J sold $22,061 worth of shares (6,939 units at $3.18), decreasing direct ownership by 6% to 111,811 units (SEC Form 4)

$MXCT SEC Filings

SEC Form 10-Q filed by MaxCyte Inc.

MaxCyte Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

SEC Form DEF 14A filed by MaxCyte Inc.

$MXCT Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Craig Hallum initiated coverage on MaxCyte with a new price target

Cowen resumed coverage on MaxCyte

Wedbush initiated coverage on MaxCyte with a new price target

$MXCT Leadership Updates

Live Leadership Updates

MaxCyte Announces Streamlined Operations and Raises 2024 Revenue Guidance

MaxCyte Appoints Cynthia Collins to its Board of Directors

MaxCyte Appoints Ali Soleymannezhad as Chief Commercial Officer

$MXCT Press Releases

Fastest customizable press release news feed in the world

MaxCyte Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Guidance

MaxCyte to Report First Quarter 2025 Financial Results on May 7, 2025

MaxCyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Guidance

$MXCT Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

President and CEO Masoud Maher bought $489,066 worth of shares (100,000 units at $4.89) (SEC Form 4)

Recent Analyst Ratings for
$MXCT

$MXCT
Financials

$MXCT
Large Ownership Changes

$MXCT
Insider Trading

$MXCT
SEC Filings

$MXCT
Analyst Ratings

$MXCT
Leadership Updates

$MXCT
Press Releases

$MXCT
Insider Purchases